More drugmakers are seeing potential in the business of producing copycat versions of expensive biotechnology drugs as U.S. guidelines take shape. The topic was at the forefront of plans discussed by several executives at this week’s JP Morgan healthcare conference in San Francisco. Kevin Sharer, chief executive officer at Amgen Inc, said the world’s largest [...]
There are many possible ways to kill a cancer cell, and one of them is to cook them to death. There are nanoparticles worth their weight in gold to do just that. Researchers at the Niels Bohr Institute at the University of Copenhagen are experimenting with tiny gold particles’ ability to melt the lipid membranes [...]
Several big biotech and pharma companies have been buzzing about their plans to launch biosimilar programs now that the FDA is laying out a regulatory pathway for the therapies. Reuters pinned down several CEOs at the JP Morgan event, and Amgen’s Kevin Sharer as well as Biogen Idec’s George Scangos talked up plans to fire [...]
As investors lay down their final bets on the FDA’s looming decision on MannKind’s Afrezza, the company’s wealthy CEO has opted to put his money where his mouth has been–doubling down on an ambitious wager that the much-maligned inhaled insulin treatment Afrezza will get a green light from regulators.
Researchers in the United States have developed a medical model for regenerating bladders using stem cells harvested from a patient’s own bone marrow. The research, published in Stem Cells, is especially relevant for paediatric patients suffering from abnormally developed bladders, but also represents another step towards new organ replacement therapies.
Big upfront fees are out. Milestones are in. Partnerships will stay hot. The IPO window will stay open, despite a lackluster record in 2010. And investor confidence will grow, helping public biotech companies outperform the general market.
Remarkable progress in understanding how stem cell biology works has been reported by a team of leading scientists, directed by experts at UC Santa Barbara. Stem cell biology is making waves around the world with great hope for the eventual repair of parts of the body. While many scientists see these breakthroughs as viable, there [...]
UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment. The finding could lead to a better understanding of how newborns respond to both infections and vaccines, [...]
New molecular tools developed at the University of Michigan show promise for “cleansing” the brain of amyloid plaques, implicated in Alzheimer’s disease.
A fledgling biotech company is pursuing some of the research into cancer stem cells undertaken by Robert Weinberg at the Massachusetts Institute of Technology and the Whitehead Institute for Biomedical Research. Verastem raised $16 million a few weeks ago with an eye on developing new treatments tailored for fighting the unique stem cells, which are [...]
You are currently browsing the weblog archives.
Longer entries are truncated. Click the headline of an entry to read it in its entirety.
Biotech Trading Signals Pharma News Biotech News